OcellO is a contract research organization which offers phenotypic screening and compound profiling services to the biotech and pharmaceutical industry, and academia. OcellO uses a proprietary best-in-class high throughput 3D cell culture-based screening platform. This technology allows high content imaging to be applied to compound screening, lead and target validation, providing rich information about compound properties.